CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares FallZacks Investment Research • 05/06/25
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEBusiness Wire • 05/05/25
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALLBusiness Wire • 04/28/25
CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025Business Wire • 04/23/25
Diabetes Care Publishes Results From Prevalence Phase Of Corcept's CATALYST Trial In People With Difficult-To-Control Type 2 DiabetesBusiness Wire • 04/21/25
It's Still Early For Corcept: With Multiple Growth Opportunities Ahead, It's No Longer Just A One Drug WonderSeeking Alpha • 04/15/25
Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian CancerBusiness Wire • 04/07/25
Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?Zacks Investment Research • 04/02/25
Corcept Therapeutics: New PROC SOC Treatment Option With Relacorilant Data ReleaseSeeking Alpha • 04/01/25
CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study GoalZacks Investment Research • 04/01/25
Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price ForecastBenzinga • 03/31/25
Corcept Therapeutics shares surge on positive late-stage ovarian cancer trial resultsProactive Investors • 03/31/25
Primary Endpoint Met in Corcept's Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian CancerBusiness Wire • 03/31/25
Levi & Korsinsky Reminds Corcept Therapeutics Incorporated Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CORTAccesswire • 03/31/25
Did Corcept Therapeutics Incorporated Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CORTAccesswire • 03/28/25
Corcept Therapeutics Incorporated (CORT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky InvestigatesAccesswire • 03/27/25